<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01944995</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01524-39</org_study_id>
    <secondary_id>2012-36</secondary_id>
    <nct_id>NCT01944995</nct_id>
  </id_info>
  <brief_title>Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis</brief_title>
  <official_title>Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nasal continuous positive airway pressure (nCPAP), widely used in neonatal intensive care is&#xD;
      also more and more used in infants with severe acute bronchiolitis. There is no evidence that&#xD;
      nCPAP improves outcome, but several studies showed that it reduces work of breathing (WOB),&#xD;
      improves gas exchange and decreases intubation rate. High flow nasal prong (HFNP) therapy,&#xD;
      also used in neonatal units, has recently been suggested for bronchiolitis management. This&#xD;
      technique allows warmed and moist gas administration protecting nasal mucosa, and preventing&#xD;
      variations of inspired gas FiO2. HFNP also creates a continuous positive pressure, reducing&#xD;
      WOB, and seems much more comfortable and better tolerated by babies than nCPAP. There are no&#xD;
      studies comparing both techniques for bronchiolitis management. The main objective of this&#xD;
      study is to compare WOB with nCPAP and HFNP therapy in infants with severe bronchiolitis in&#xD;
      pediatric intensive care unit. Secondary purpose is to compare efficacy and tolerance of both&#xD;
      techniques. We propose to lead an open, single center, crossover randomized study. Each&#xD;
      patient will receive the two treatments. Three consecutive periods will be studied: first one&#xD;
      (minimum 2 hours), with the first technique CPAP or HFNP according to randomization&#xD;
      (treatment 1); second period (2 hours) with the second technique (treatment 2); Third period&#xD;
      (6 hours) with the second technique. The primary endpoint will be the comparison of WOB&#xD;
      (estimated by the calculation of the transdiaphragmatic pressure-time product) at the end of&#xD;
      the two firsts periods. Efficacy and tolerance of each technique will be evaluated and&#xD;
      compared by compared measuring respiratory rate, heart rate, FiO2, SpO2, transcutaneous PCO2,&#xD;
      modified Wood score, and EDIN score during the third period. Nine subjects by groups are&#xD;
      required.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>calculation of the trans-diaphragmatic pressure</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the effectiveness of treatments</measure>
    <time_frame>12 months</time_frame>
    <description>respiratory and hemodynamic parameters: ( Respiratory rate; Heart Rate; blood pressure; Clinical signs of struggle)&#xD;
haematosis ( SpO2 ; FiO2 ; transcutaneous PCO2 )</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>glasses broadband</intervention_name>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal CPAP</intervention_name>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants less than 3 months&#xD;
&#xD;
          -  Infants hospitalized in the pediatric intensive care unit of the hospital in northern&#xD;
             Marseille for an episode of acute viral bronchiolitis, defined by the French consensus&#xD;
             conference of 2000 (1) clinical signs of infection of the upper airways with&#xD;
             tachypnea, brake expiratory and / or wheezing auscultation, signs of struggle&#xD;
&#xD;
          -  Infants with acute respiratory distress score with Wood changed&gt; 3 and requiring&#xD;
             ventilatory Support&#xD;
&#xD;
          -  Infants whose parents or legal guardians have accepted their participation in the&#xD;
             research and signed informed consent.&#xD;
&#xD;
          -  With Social Security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Clinical condition requiring immediate intubation before the start of treatment to&#xD;
             the:&#xD;
&#xD;
               -  severity of respiratory distress: FiO2&gt; 60% to maintain SpO2&gt; 92%&#xD;
&#xD;
               -  hemodynamic instability&#xD;
&#xD;
               -  the occurrence of apneas d√©saturantes (respiratory pauses greater than 20 seconds&#xD;
                  duration associated with desaturation &lt;80% and / or bradycardia &lt;80/min)&#xD;
&#xD;
               -  the presence of neurological disorders with altered consciousness&#xD;
&#xD;
          -  Presence of co-morbidities:&#xD;
&#xD;
               -  chronic respiratory failure&#xD;
&#xD;
               -  heart&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LOIC MONDOLONI</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>fabrice michel</last_name>
    <email>fabrice.michel@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>fabrice MiCHEL</last_name>
      <email>fabrice.michel@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>fabrice michel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>September 13, 2013</study_first_submitted>
  <study_first_submitted_qc>September 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2013</study_first_posted>
  <last_update_submitted>August 27, 2014</last_update_submitted>
  <last_update_submitted_qc>August 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

